MTOR and hepatocellular carcinoma: Meanwhile, SL exerted anti-HCC effects through multiple pathways, including suppression of Ki-67 expression and HGF/cMet, Wnt/β-catenin, and PI3K/Akt/mTOR pathways and enhancement of antioxidant defense mechanisms (Yassin et al., 2022).